Single-Dose Study Of PF-04603629 In Type 2 Diabetic Subjects

NCT00638313 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

BIOLOGICAL: Placebo
BIOLOGICAL: PF-04603629

Sponsor

Pfizer